reduced results from

147 billion

123 million

3 million

41553

to ~255 options

options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications

what is 'ca 15-3 (cancer antigen 15.3)'? Definition for CA 15-3 (cancer antigen 15.3) CA 15-3 (cancer antigen 15.3) is also known as: CA 15-3, cancer antigen 15.3 CA 15-3 (cancer antigen 15.3) is a medical procedure used for such diagnoses as: metastases, breast cancer in females and malignancy. related diagnosis for 'ca 15-3 (cancer antigen 15.3)' 1 - 3 of 3 diagnosis metastases spread of malignant tumors to other body sites CA 15-3 (cancer antigen 15.3) and metastases breast cancer in females cancer of the breast in females CA 15-3 (cancer antigen 15.3) and breast cancer in females malignancy cancer CA 15-3 (cancer antigen 15.3) and malignancy related procedure for 'ca 15-3 (cancer antigen 15.3)'/associated diagnoses 1 - 5 of 171 procedures Needle Biopsy CA 15-3 (cancer antigen 15.3) and Needle Biopsy Biopsy CA 15-3 (cancer antigen 15.3) and Biopsy Brachytherapy Sealed source radiotherapy CA 15-3 (cancer antigen 15.3) and Brachytherapy Breast Self Exams CA 15-3 (cancer antigen 15.3) and Breast Self Exams CA 27.29 ((cancer antigen 27.29) CA 15-3 (cancer antigen 15.3) and CA 27.29 ((cancer antigen 27.29) CT scan CA 15-3 (cancer antigen 15.3) and CT scan Carcinoembryonic Antigen (CEA) CA 15-3 (cancer antigen 15.3) and Carcinoembryonic Antigen (CEA) Chemotherapy Use of chemical substances to treat disease CA 15-3 (cancer antigen 15.3) and Chemotherapy Chest X-ray Radiological technique to image the chest CA 15-3 (cancer antigen 15.3) and Chest X-ray Clinical breast exam (CBE) CA 15-3 (cancer antigen 15.3) and Clinical breast exam (CBE) Estrogen receptors CA 15-3 (cancer antigen 15.3) and Estrogen receptors Excision biopsy CA 15-3 (cancer antigen 15.3) and Excision biopsy External Beam Radiation CA 15-3 (cancer antigen 15.3) and External Beam Radiation FDG PET scan CA 15-3 (cancer antigen 15.3) and FDG PET scan Flow Cytometry CA 15-3 (cancer antigen 15.3) and Flow Cytometry Image Cytometry CA 15-3 (cancer antigen 15.3) and Image Cytometry Immunotherapy CA 15-3 (cancer antigen 15.3) and Immunotherapy Liver Function Tests elevated liver enzymes CA 15-3 (cancer antigen 15.3) and Liver Function Tests Lymph node biopsy CA 15-3 (cancer antigen 15.3) and Lymph node biopsy Mammogram Mammogram CA 15-3 (cancer antigen 15.3) and Mammogram for more please login, login is free (click to login) related medication for 'ca 15-3 (cancer antigen 15.3)'/associated diagnoses 1 - 5 of 171 drugs paclitaxel CA 15-3 (cancer antigen 15.3) and paclitaxel anastrozole CA 15-3 (cancer antigen 15.3) and anastrozole bevacizumab CA 15-3 (cancer antigen 15.3) and bevacizumab cyclophosphamide CA 15-3 (cancer antigen 15.3) and cyclophosphamide docetaxel CA 15-3 (cancer antigen 15.3) and docetaxel doxorubicin CA 15-3 (cancer antigen 15.3) and doxorubicin epirubicin CA 15-3 (cancer antigen 15.3) and epirubicin exemestane CA 15-3 (cancer antigen 15.3) and exemestane fulvestrant CA 15-3 (cancer antigen 15.3) and fulvestrant gemcitabine CA 15-3 (cancer antigen 15.3) and gemcitabine letrozole CA 15-3 (cancer antigen 15.3) and letrozole megestrol acetate CA 15-3 (cancer antigen 15.3) and megestrol acetate methotrexate CA 15-3 (cancer antigen 15.3) and methotrexate tamoxifen CA 15-3 (cancer antigen 15.3) and tamoxifen topoisomerase inhibitors CA 15-3 (cancer antigen 15.3) and topoisomerase inhibitors toremifene CA 15-3 (cancer antigen 15.3) and toremifene trastuzumab CA 15-3 (cancer antigen 15.3) and trastuzumab 5-fluorouracil (5-fu) CA 15-3 (cancer antigen 15.3) and 5-fluorouracil (5-fu) 6-mercaptopurine (6-mp) CA 15-3 (cancer antigen 15.3) and 6-mercaptopurine (6-mp) actinomycin-d CA 15-3 (cancer antigen 15.3) and actinomycin-d for more please login, login is free (click to login) The following are types of physicians relevant for 'CA 15-3 (cancer antigen 15.3)'. related types of physicians 'family practitioner, internist, oncologist' show local physicians postal code Find Local stars represent relevance to topic not rating more The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested. web search results for 'ca 15-3 (cancer antigen 15.3)'? Results 1 - 50 - CA 15-3 (cancer antigen 15.3) Value of carcinoembryonic antigen (CEA) and cholesterol assays of ... CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 ... Cancer. 1991 Oct 15;68(8):1808?1814. [PubMed] ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1731306   www.pubmedcentral.nih.gov - summary Tumor Markers - Blood Tests for Breast Cancer - Tumor Markers What is the cancer antigen 15-3 (CA 15-3) blood test for breast cancer? Cancer Antigen 15-3 (CA 15-3) is a blood test that is given during or after ... http://breastcancer.about.com/od/tumormarkers/Tumor_Markers_...   breastcancer.about.com - summary Publications - 1997 J Chronic Fatigue Syndrome 1997;3:15-28. Dominguez G, Black JB, Stamey FR, ... A, Frias M, Ramirez T. CA 15.3 in breast cancer: Comparison of two assays and ... http://www.cdc.gov/ncidod/dvrd/about/pub97.htm   www.cdc.gov - summary ChemIDPlus/HSDB 15972-60-8 Toxicity - National Toxicology Program ... who left Iowa (< 1/3 the cohort) did not have cancer incidence assessed but were ... Systemic toxicity was noted at 15 mg/kg/day, highest dose tested (HDT), as ... http://ntp.niehs.nih.gov/index.cfm?objectid=E87E1001-BDB5-82F8-F4408C718BD55C42   ntp.niehs.nih.gov - summary Basic fibroblast growth factor and vascular endothelial growth factor ... ... factor) and CA 15.3 in the monitoring of breast cancer patients. Anticancer ... antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA) in comparison with ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?&artid=314457   www.pubmedcentral.nih.gov - summary Analysis of Expressed and Non-Expressed IGK Locus Rearrangements in ... Antigen encounter in the bone marrow may reinduce RAG gene expression so that ... IGKV-J rearrangements in ?-CLL, 15, 3, and 10 sequences had, respectively, 100%, ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1449522   www.pubmedcentral.nih.gov - summary BRD4 - Wikipedia, the free encyclopedia French CA, Miyoshi I, Aster JC, et al. ( 2001) ... Cloned fusion product from a rare t(15;19)(q13.2;p13.1) inhibit S phase in vitro. ... http://en.wikipedia.org/wiki/BRD4   en.wikipedia.org - summary ocr (25,755 Bytes) ... been reported (14, 15) to possess the group-specific antigen of the mammalian ... Special Virus Cancer Program Contract 70-2049 and Research Grant CA-02332. ... http://profiles.nlm.nih.gov/PX/B/B/C/G/_/pxbbcg.ocr   profiles.nlm.nih.gov - summary The role of preoperative biopsy in pancreatic cancer Higher values of CEA, CA 125 and CA 15-3 are typical of mucinous carcinomas. ... levels of pancreatic enzymes and low levels of CEA, NB70/K, CA 72-4 and CA 15.3. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2020672   www.pubmedcentral.nih.gov - summary Abstracts ... and cisplatin (15), and gemcitabine and cisplatin followed by oxaliplatin (3) ... The pancreatic cancer database was queried for all patients with pancreatic ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2023963   www.pubmedcentral.nih.gov - summary Simple method for comparing reliability of two serum tumour markers in ... ... Frick A, Prinz H. CA 15.3 as a tumour marker in breast cancer. ... antigen in monitoring breast cancer patients in comparison with CA 15-3. Eur J Cancer. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=501827   www.pubmedcentral.nih.gov - summary Cluster Analysis of Invasive Meningococcal Disease | CDC EID Jackson LA, Alexander ER, DeBolt CA, Swenson PD, Boase J, McDowell MG, et al. ... 729 (15) W135 (%) 4 (1) 5 (1) 7 (1) 3 (1) 6 (1) 4 (1) 12 (2) 12 (2) 7 (2) 60 (1) X ... http://www.cdc.gov/NCIDOD/EID/vol10no9/03-0992.htm   www.cdc.gov - summary Activation of bone marrow-resident memory T cells by circulating ... BM was harvested 3 to 15 days after surgery, and in one experiment, mice were ... dendritic cells in cancer immunotherapy. Curr. Opin. Immunol. 2003;15:138?47. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary ALDH1 is a marker of normal and malignant human mammary stem cells and ... According to the cancer stem cell model, tumors originate in either tissue stem ... Figure 3 ... Antigen enhancement was done by incubating the sections in ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary SMOKING t I and HEALTH a report of the Surgeon General Cl The ... Chapter 5.-Ca rmr. National Cancer Institute. ... National Cancer Institute PART II BEHAVIORAL ASPECTS OF SMOKING 15. Biological ... http://profiles.nlm.nih.gov/NN/B/C/M/D/_/nnbcmd.ocr   profiles.nlm.nih.gov - summary Mechanism of UV-related carcinogenesis and its contribution to nevi ... The development of skin cancer in humans is associated with persistent changes ... 2005;15(3):213?7. [PubMed] 27. Hu DN, Yu GP, McCormick SA, Schneider S, Finger PT. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic ... ... carcinoembryonic antigen and CA 15.3, enzymes (amylase, lipase, and amylase ... glycoprotein (TAG-72) identified by monoclonal antibody B72.3. Cancer Res. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1243114   www.pubmedcentral.nih.gov - summary SePaCS?a web-based application for classification of seroreactivity ... ... antigen (PSA) that is widely used in the diagnosis of prostate cancer (3) ... single antigen markers including CA-19.9 (pancreatic cancer) and CA-15.3 (breast ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1933220   www.pubmedcentral.nih.gov - summary Abstracts ... YTTRIUM-90 MICROSPHERE TREATMENT IN THE MANAGEMENT OF UNRESECTABLE LIVER CANCER ... 15 patients were treated: 12 after liver surgery and 3 after liver trauma ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2023810   www.pubmedcentral.nih.gov - summary Purines 2008 Meeting 29 June ? 2 July 2008, Copenhagen, Denmark In vitro pharmacological data for 2?(3?)-C-methyl-ATP (compounds 1 and 2, ... Roche Pharmaceuticals, 3431 Hillview Avenue, Palo Alto, CA 94304, USA ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2432466   www.pubmedcentral.nih.gov - summary N C H S - Journal articles, 2002 Statistics in Medicine 2002 May 15;21(9):1189-212. ... An estimated 8% of children 3-17 years of age had a learning disability, and an ... http://www.cdc.gov/nchs/products/pubs/journal/abstract02.htm   www.cdc.gov - summary Long-Term Multiepitopic Cytotoxic-T-Lymphocyte Responses Induced in ... ... route of immunization elicits strong and stable CTL responses (3, 7, 15, 48) ... falciparum liver-stage antigen 3 induces protection against Plasmodium ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=470687   www.pubmedcentral.nih.gov - summary ftp.cdc.gov/pub/EID/vol1no4/ascii/vol1no4.txt Articles should be approximately 3,500 words and should include references, not ... An immunofluorescence test for rabies viral antigen developed in the 1950s. ... http://ftp.cdc.gov/pub/EID/vol1no4/ascii/vol1no4.txt   ftp.cdc.gov - summary Critical roles of the guanylyl cyclase B receptor in endochondral ... A mouse glyceraldehyde-3-phosphate dehydrogenase control amplimer set (Clontech) ... 15 and 16. Bone specimens were decalcified in 14% EDTA that was prepared in ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=534612   www.pubmedcentral.nih.gov - summary The lesser pestilence: non-epidemic puerperal fever. 1989 Aug 3;321(5):298?302. [PubMed] ... specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA. ... 1995 15(4):1609?1611.Jul?Aug; ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1036271   www.pubmedcentral.nih.gov - summary 25 inbred strains of mice as possible candidates for a multi-strain ... strain in cancer and immunology research (Festing, 1969), though its popularity has ... methylcholanthrene (4/15 males, 3/15 females) (Strong, 1952) ... http://ntp.niehs.nih.gov/files/MouseStrains_Festing.pdf   ntp.niehs.nih.gov - summary Prostate Cancer Pathology, Screening, and Epidemiology ... to be screened for prostate cancer, and 15,350 were allocated to the control unscreened group. ... and non-curable prostate cancer.3,4 The approach used is ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1476077   www.pubmedcentral.nih.gov - summary Disseminated bony metastases following incidental gallbladder cancer ... ... tumour markers CA 19.9, CA 125, CA 15.3, carcinoembryogenic antigen (CEA) and ... 3. Donohue JH, Nagorney DM, Grant CS, Tsushima K, Ilstrup DM, Adson MA. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2020591   www.pubmedcentral.nih.gov - summary Early detection of ovarian cancer: background, rationale, and structure ... Clinical correlations of ovarian cancer antigen NB/70K: a preliminary report. ... Serum CA 125, CA 15.3 and CA 19.9 levels and surgical findings in patients ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2589429   www.pubmedcentral.nih.gov - summary Metastatic Breast Tumour Regression Following Treatment by a Gene ... ... (National Cancer Institute of Canada-Common Toxicity Criteria) grade 3/4 abnormal ... CA-15.3 levels increased only slightly in this patient and remained ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=400208   www.pubmedcentral.nih.gov - summary Frequent Epigenetic Inactivation of SYK Gene in Human Hepatocellular ... ... DNA methylation in breast cancer (15) and T-lineage acute lymphoblastic leukemia ... status of SYK, E-cadherin, and TIMP-3 promoter regions (15, 26, 27) ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1832152   www.pubmedcentral.nih.gov - summary Protein microarrays for highly parallel detection and quantitation of ... ... as a function of the concentration of the cognate antigen (Figure 3) ... 2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Surveillance of Certain Health Behaviors and Conditions Among States ... ... was 33% (objective no. 3-12); no state or territory, 15 MMSAs, and 27 counties ... cervical cancer incidence and mortality have declined in the United States (15) ... http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5707a1.htm?s_cid=ss5707a1_e   www.cdc.gov - summary Expression of lnterleukin-8 Correlates with Angiogenesis ... The PC-3 human prostate cancer cell line was originally obtained from the ... PC-3 IL-8 high cells had 15.3-fold higher expression of IL-8 mRNA than PC-3 IL-8 ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Serum protein markers for early detection of ovarian cancer ... TAG 72.3, CA-15.3, and CA-125. The most commonly used biomarker is CA-125, which ... of 40 individuals (8 healthy, 32 EOC cancer patients, including 3 with stage ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Lab Test Cancer Antigen 15-3, MUC-1, Mucin-Like Carcinoma. Department: Laboratory Medicine. Lab Area: ... Measurement of CA 15.3 is not useful as a cancer-screening test. ... http://cclnprod.cc.nih.gov/dlm/testguide.nsf/Index/27FD4EF45...   cclnprod.cc.nih.gov - summary Antigène carcino-embryonnaire - Wikipédia ACE - Alpha-f?toprotéine - CA 125 - CA 15.3 - CA 19.9 - CYFRA 21-1 - HCG - Gastrine - PSA ... Dernière modification de cette page le 2 février 2009 à 15:45. ... http://fr.wikipedia.org/wiki/Antig%C3%A8ne_carcino-embryonnaire   fr.wikipedia.org - summary Second-Look Surgery in Patients With Peritoneal Dissemination From ... ... panel with carcinoembryonic antigen, CA 19-9, CA-125, CA 15.3, and CA 72.4. ... 15. Hacker NF, Berek JS. Cytoreductive surgery for ovarian cancer. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1422006   www.pubmedcentral.nih.gov - summary CLINICAL VIGNETTES Laboratory data showed serum WBC 15,000/mm3 with a left shift. ... On day 3 her creatinine level increased and urinalysis revealed numerous ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1492602   www.pubmedcentral.nih.gov - summary Morbidity and Mortality Weekly Report cancer and obstructive lung disease (3,4) ... 2006;15:3?4. 6. Brener ND, Kann L, McMannus T, Kinchen SA, Sundberg EC, Ross. JG. ... http://www.cdc.gov/mmwr/PDF/wk/mm5520.pdf   www.cdc.gov - summary Analysis of Signal Transducer and Activator of Transcription 3 (Stat 3 ... ... 10 to 18.72; median, 15.3); and 3) negative or low cyclin D1 ... Group 2 included 15 cases with cyclin D1 expression and no activation of Stat 3 protein. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1851203   www.pubmedcentral.nih.gov - summary Antigène prostatique spécifique - Wikipédia ACE - Alpha-f?toprotéine - CA 125 - CA 15.3 - CA 19.9 - CYFRA 21-1 - HCG - Gastrine - PSA ... Dernière modification de cette page le 19 mars 2009 à 15:47. ... http://fr.wikipedia.org/wiki/Antig%C3%A8ne_prostatique_sp%C3%A9cifique   fr.wikipedia.org - summary Predictive Value of PTEN and AR Coexpression of Sustained ... Prostate-specific antigen level at the time of surgery was 10 ng/ml in only 10 ... the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2517639   www.pubmedcentral.nih.gov - summary Gene expression variation to predict 10-year survival in lymph-node ... CA Cancer J Clin. 2006;56:106?130. [PubMed] ... of a new tumour-associated antigen TM4SF5 and its expression in human cancer. Gene. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2559847   www.pubmedcentral.nih.gov - summary Mosaic blood vessels in tumors: Frequency of cancer cells in contact ... ... Department of Anatomy, University of California, San Francisco, CA 94143 ... human carcinoembryonic antigen (Dako) to ... 1966;15:464?478. [PubMed] 3. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Molecular Detection of Micrometastatic Breast Cancer in Histopathology ... ... and mamB have particular promise for breast cancer detection.15,32,33 ... 2 oncoprotein, CEA, and CA 15.3 in patients with breast cancer: prognostic value. ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary Cytochrome P450 aromatase expression in human seminoma Endocr Rev. 1994;15:342?355. doi: 10.1210/er.15.3.342. [PubMed] ... Antigen retrieval in formalin fixed, paraffin-embedded tissues: an enhancement ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary THE ROLE OF ESTROGEN IN THE INITATION OF BREST CANCER Epithelial membrane antigen (EMA) had similar level of reactivity ... to be deleted are 4p16.3 (50 %), 4p15.1-15.3 (57%), 4q25-26 (63%), and 4q33-34 (76%) (61) ... http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...   www.pubmedcentral.nih.gov - summary CA 125 - Wikipédia CA 125, est l'abréviation de carbohydrate antigen 125[1] (souvent appelé cancer antigen 125) ... Alpha-f?toprotéine - CA 125 - CA 15.3 - CA 19.9 - CYFRA 21 ... http://fr.wikipedia.org/wiki/CA_125   fr.wikipedia.org - summary vol5no2.txt At least 15,000 Year rals dic genic lial (sup c)(sup c)Total are receiving care. ... Syphilis On average, 3,000 new cases and 1,000 late cases of syphilis are ... http://ftp.cdc.gov/pub/EID/vol5no2/ascii/vol5no2.txt   ftp.cdc.gov - summary show more 1  2

Chat with eNurse Kim about 'CA 15-3 (cancer antigen 15.3)' or something else! quick facts related diagnosis category oncology female reproductive system-gynecological